97165 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
Ion concentration-dependent binding molecule library
#302Method for producing antibody
#303Monoclonal antibody of human-derived procalcitonin, and preparation method and application thereof
#304ANTI-NEUROTENSIN ANTIBODIES AND USES THEREOF
#305ELP fusion proteins for controlled and sustained release
#306Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
#307Compositions and methods for assessing the risk of cancer occurrence
#308COMPOSITIONS AND METHODS FOR DETECTING AND TREATING GASTRIC CANCER
#309Compositions and methods for detecting and treating esophageal cancer
#310Anti-adrenomedullin (ADM) monoclonal antibodies and anti-ADM monoclonal antibody fragments that bind to adrenomedullin
#311Superagonist polypeptide analogs of adrenomedullin and intermedin peptide hormones
#312Compositions and methods for detecting and treating ovarian cancer
#313MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#314T cell receptors and immune therapy using the same
#315ANTIGEN-BINDING PROTEINS TO MARINOBUFAGENIN
#316Modulators
#317LEAP2 binding agents and compositions thereof
#318Polynucleotides encoding relaxin
#319Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
#320PACAP antibodies and uses thereof
#321Pathway specific markers for diagnosing irritable bowel syndrome
#322Cortistatin analogues and syntheses and uses thereof
#323Methods of treating or preventing pruritis by blocking natriuretic polypeptide b
#324PERIPHERAL NEUROPATHY DIAGNOSIS
#325Monoclonal antibodies directed to peptide in the context of MHC and methods of making and using monoclonal antibodies
#326Methods and compositions related to functional polypeptides embedded in heterologous protein scaffolds
#327Personalized medicine therapeutic MiniCircle
#328SYSTEM AND METHOD FOR DETECTION OF NEUROTRANSMITTERS AND PROTEINS IN THE CARDIAC SYSTEM
#329Anti-PD-L1-anti-TIM-3 bispecific antibodies
#330Polypeptides, nucleic acids and uses thereof
#331IGF2BP3 functional alterations and overexpression as a marker for cancer diagnosis and therapeutic response to IGF1R inhibitors
#332Antibodies to human erythroferrone and uses thereof
#333Anti-mullerian hormone (AMH) neutralizing antibodies and uses thereof
#334Human endothelin receptor antibody and use thereof
#335Method of obtaining a binder to prepro-vasopressin or fragments thereof
#336Anti-thyroglobulin T cell receptors
#337Antibody against alopecia-inducing substance as antigen, composition and production method
#338ANTIBODIES THAT RECOGNIZE IAPP
#339REAGENT KIT USED FOR DETECTING GASTRIN-17, AND PREPARATION METHOD AND APPLICATION FOR REAGENT KIT
#340Nucleic acids encoding antibodies to Kallidin and des-Arg-Kallidin and host cells comprising the same
#341Anti-CGRP compositions and use thereof
#342Anti-CGRP compositions and use thereof
#343Anti-CGRP compositions and use thereof
#344Method for controlling affinity of antibody for antigen, antibody whose affinity for antigen has been altered, and its production method
#345Compounds capable of antagonizing islet amyloid polypeptide (IAPP) induced beta-cell damage and impaired glucose tolerance
#346ANTIBODIES THAT RECOGNIZE IAPP
#347Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
#348Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
#349Phage display library, members thereof and uses of the same
#350PATHWAY SPECIFIC ASSAYS FOR PREDICTING IRRITABLE BOWEL SYNDROME DIAGNOSIS
#351Mitigating Tissue Damage and Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (LTBP4)
#352Anti-CGRP antibody formulation
#353Method of Modulating the Concentration of Proteins in Cerebrospinal Fluid
#354Hepcidin antagonists for use in the treatment of inflammation
#355Anti-hepcidin antibodies and uses thereof
#356METHODS FOR TREATING MELANOMA
#357Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof
#358Compositions and methods for treating fatty tissue buildup
#359Non-natural Semaphorins 3 and their medical use
#360Monoclonal antibodies to progastrin and their uses
#361Methods and means for the production of Ig-like molecules
#362Anti-active GIP antibody
#363HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (HNGAL) MUTEINS THAT BIND HEPCIDIN AND NUCLEIC ACID ENCODING SUCH
#364Blockers of the growth hormone receptor in disease prevention and treatment
#365Alpha-cell re-generation combined with conversion to beta cells
#366Anti-ACTH antibodies and use thereof
#367Methods and means for the production of Ig-like molecules
#368Methods of increasing sarcolemmal utrophin
#369Pathway specific markers for diagnosing irritable bowel syndrome
#370Monoclonal antibodies to progastrin and their uses
#371Monoclonal antibodies to progastrin and their uses
#372Anti-PACAP antibodies and uses thereof
#373Humanized anti-PACAP antibodies and uses thereof
#374Anti-hepcidin antibodies and uses thereof
#375Methods of Treating Chronic Pain
#376Method for measurement of vitamin D
#377Methods for detecting 1,25-dihydroxyvitamin D and related antibodies
#378Humanized anti-hepcidin antibodies and uses thereof
#379Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
#380Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
#381Antagonist antibodies directed against calcitonin gene-related peptide
#382Anti-neurotensin antibodies and uses thereof
#383Prophylaxis of colorectal and gastrointestinal cancer
#384ANTI-GLUCAGON ANTIBODIES AND USES THEREOF
#385Methods for treatment using anti-NMU agents
#386Anti-neurotensin long fragment antibodies and uses thereof
#387Stable Dual Variable Domain Immunoglobulin Protein Formulations
#388METHODS OF TREATING DIABETES AND COMPOSITIONS CAPABLE OF SAME
#389Ligands that potentiate the bioactivity of gonadotropins
#390Ligands that potentiate the bioactivity of gonadotropins
#391Monoclonal antibodies to progastrin and their uses
#392Immunoassay for the detection of procalcitonin
#393PROLACTIN RECEPTOR ANTAGONISTS FOR TREATMENT OF GLIOBLASTOMA
#394Use of negative functional modulators of erythropoietin for therapy
#395Fab fragment libraries and methods for their use
#396Antagonists for abdominal vasopressin V2 receptor and uses thereof
#397Provasopressin antagonists and uses thereof
#398Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase
#399PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEADACHE
#400METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE
#401Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin D metabolite
#402Covalently linked helicar-anti-helicar antibody conjugates and uses thereof
#403Compositions and methods for treating fatty tissue buildup
#404Anti-ANGPTL8 antibodies and uses thereof
#405Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment
#406Compositions and methods for treating cancers associated with ETBR activation
#407Cortistatin analogues and syntheses and uses thereof
#408Anti-erythropoietin antibodies
#409Methods of treating or preventing pruritis by blocking natriuretic polypeptide B
#410Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP
#411Adrenomedullin to guide therapy of blood pressure decline
#412Methods of determining whether anti-PACAP (adenylate cyclase-activating peptide) antibodies or anti-PACAP antigen binding fragments inhibit PACAP-associated photophobia or light aversion
#413COMPOSITIONS AND METHODS FOR TREATING OBESITY
#414Methods for treating pain using antibodies to Kallidin and des-Arg-Kallidin
#415ANTI-PACAP ANTIBODIES AND USES THEREOF
#416Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia
#417Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes
#418LEPTIN IN IMMUNE MODULATION
#419Adrenomedullin binder for use in therapy of cancer
#420Polypeptides, nucleic acids and uses thereof
#421Anti-PACAP antibodies
#422Antibody against alopecia-inducing substance as antigen, composition and production method
#423Methods for stimulation of appetite and increase in weight by administration of asprosin
#424Compositions and methods for antibodies targeting Epo
#425Antibody Compositions and Immunoassay Methods to Detect Isoforms of Anti-Müllerian Hormone
#426Viral vectors for expressing a modified mullerian inhibiting substance (MIS) protein
#427TREATMENT OF DIABETES MELLITUS, METHODS AND COMPOSITIONS THEREFOR
#428Humanized anti-ACTH antibodies and use thereof
#429Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
#430METHOD FOR EVALUATING SALIVARY ADIPONECTIN LEVEL AND KIT FOR MEASURING SALIVARY ADIPONECTIN LEVEL
#431GIP AND GLP-1 RECEPTOR DUAL-AGONISTS FOR THE TREATMENT OF DIABETES
#432Labeled ligands of anti-Mullerian hormone for diagnosis of endometriosis
#433Use of proinsulin for immune system modulation
#434Methods and means for the production of Ig-like molecules
#435METHOD OF TREATING A PATHOLOGICAL SYNDROME AND A PHARMACEUTICAL AGENT
#436THROMBOPOIETIN RECEPTOR LIGANDS FOR NEUROPROTECTION
#437Method of modulating the activity of adrenomedullin in a subject in need of therapeutic intervention for organ dysfunction or organ failure associated with adranomedullin (ADM) activity by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment to the subject
#438COMPOITIONS AND METHODS FOR MODULATING THERMOGENESIS USING PTH-RELATED AND EGF-RELATED COMPOUNDS
#439Methods of using anti-CGRP antagonist antibodies
#440Methods of modulating the activity of adrenomedullin in a subject in need of regulation of fluid balance by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment
#441Protein in which electrical interaction is introduced within hydrophobic interaction site and preparation method therefor
#442Augurin immunoassay
#443Pathway specific markers for diagnosing irritable bowel syndrome
#444Antibodies to human resistin
#445Pathway specific assays for predicting irritable bowel syndrome diagnosis
#446cgb2 And cgb1 Genes; Diagnosis, Monitoring And Treatment Of Cancer
#447TSH antibodies for point-of-care immunoassay formats
#448TSH immunoassays and processes for performing TSH immunoassays in the presence of endogenous contaminants in restricted wash formats
#449Anti-Ghrelin Antibodies and Uses Thereof
#450Anti-glucagon antibodies
#451INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE
#452Melatonin monoclonal antibody, detection, methods and uses thereof
#453Methods of treating retinal disorders with anti-apelin antibodies
#454Methods and arrays for use in the same
#455Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma
#456Anti-hepcidin antibodies and uses thereof
#457T CELL RECEPTOR MIMIC RL9A
#458Modulators
#459Method for refolding antibody, process for producing refolded antibody, refolded antibody, and uses thereof
#460Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies
#461Method and kit for detecting 1,25-dihydroxyvitamin D and related antibodies
#462Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
#463Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
#464Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
#465Signal biomarkers
#466SUPPRESSION OF LEPTIN ACTION FOR TREATMENT OF PULMONARY INFECTIONS
#467Albumin fusion proteins
#468Modulators
#469Methods of treating chronic pain
#470POLYPEPTIDES, NUCLEIC ACIDS AND USES THEREOF
#471NOVEL PEPTIDE AND APPLICATION THEREOF
#472Methods of using anti-CGRP antagonist antibodies
#473Method to treat migraines using CGRP antibodies
#474Anti-ACTH antibodies and use thereof
#475Immunogenic compositions comprising progastrin and uses thereof
#476Veterinary composition and methods for non-surgical neutering and castration
#477Immunoassay kit for quantification of BNP and proBNP
#478Albumin fusion proteins
#479METHODS AND MEANS FOR THE PRODUCTION OF IG-LIKE MOLECULES
#480ANTIBODIES THAT RECOGNIZE IAPP
#481Compositions and methods for treating fatty tissue buildup
#482MONOCLONAL ANTIBODIES TO GASTRIN HORMONE
#483Methods of managing graft versus host disease
#484Polypeptides, nucleic acids and uses thereof
#485Single-chain antibodies and other heteromultimers
#486ERG/TFF3/HMWCK triple immunostain for detection of prostate cancer
#487Methods for modulating Th1/Th2 cell balance by increasing leptin activity
#488METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND DIAGNOTIC OF ANEMIA OF INFLAMMATION
#489APELIN PEPTIDES, ANTIBODIES THERETO, AND METHODS OF USE
#490BONE REPAIR PROMOTER
#491Method for Predicting the Risk of Getting a Cardiovascular Event in a Female Subject
#492Antibodies that recognize IAPP
#493Antibodies that recognize IAPP
#494PROPHYLAXIS OF COLORECTAL AND GASTROINTESTINAL CANCER
#495Antibodies to kallidin and des-Arg-kallidin
#496Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
#497Antibody against affinity complex
#498LONG LIFE POLYPEPTIDE BINDING MOLECULES
#499Monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
#500Modulation of activity of proneurotrophins
#501ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
#502Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
#503Diagnosis and risk stratification by determining the marker CT-proADM
#504PROVASOPRESSIN ANTAGONISTS AND USES THEREOF
#505METHOD OF OBTAINING A BINDER TO PREPRO-VASOPRESSIN OR FRAGMENTS THEREOF
#506Anti-glucagon antibodies and uses thereof
#507ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR PREVENTION OR REDUCTION OF ORGAN DYSFUNCTION OR ORGAN FAILURE IN A PATIENT HAVING A CHRONIC OR ACUTE DISEASE OR ACUTE CONDITION
#508Apelin antigen-binding proteins and uses thereof
#509MARKER AND TARGET FOR RESPONSIVENESS AND RESISTANCE TO CANCER AGENTS
#510Method for removing viruses in a physiologically-active protein-containing sample
#511Adrenomedullin assays and methods for determining mature adrenomedullin
#512Methods of modulating adrenomedullin by administering an anti-adrenomedullin (ADM) antibody
#513ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OF ANTI-ADM NON-IG SCAFFOLD FOR REGULATING THE FLUID BALANCE IN A PATIENT HAVING A CHRONIC OR ACUTE DISEASE
#514METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE
#515METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE
#516PROTOCOL FOR IDENTIFYING AND ISOLATING ANTIGEN-SPECIFIC B CELLS AND PRODUCING ANTIBODIES TO DESIRED ANTIGENS
#517HEPCIDIN, HEPCIDIN ANTAGONISTS AND METHODS OF USE
#518Ion concentration-dependent binding molecule library
#519Materials and methods for modulating activity of bone marrow derived cells
#520DIAGNOSTIC USE OF PROSOMATOSTATIN
#521Antibody-mediated immunocontraception
#522Compounds for use in the treatment of Alzheimer's disease
#523Use of CGRP antagonist compounds for treatment of psoriasis
#524Method of inhibiting cancer in a mammal by administering an antibody to PTHrP
#525Methods for predicting pregnancy outcome in a subject by hCG assay
#526NOVEL FAB FRAGMENT LIBRARIES AND METHODS FOR THEIR USE
#527Compositions and methods for antibodies targeting EPO
#528Method for predicting the risk of developing a colonic neoplasia
#529NUCLEIC ACIDS ENCODING BIOLOGICALLY ACTIVE POLYPEPTIDES DERIVED FROM A NOVEL EARLY STAGE PREGNANCY FACTOR DESIGNATED MATERNIN (MA)
#530Methods and means for the production of IG-like molecules
#531Method and kit for detecting the preovulatory LH peak
#532Antibodies against angiopoietins 1 and 2, and their use
#533Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase
#534Methods and means for the production of Ig-like molecules
#535Method of treating hypertension disorder and a pharmaceutical agent
#536Antibodies to TTR and methods of use
#537Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4)
#538Method for selecting plasma cells or plasmablasts, method for producing target antigen specific antibodies, and novel monoclonal antibodies
#539COMPOSITIONS, METHODS AND KITS RELATING TO RESISTIN
#540Methods and means for the production of Ig-like molecules
#541Low dead volume extraction column device
#542BNP-SP antibodies
#543LUTEINIZING-HORMONE LIGAND AND LIGAND-GONADOTROPHIN COMPLEX
#544Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
#545Method of treating a pathological syndrome and a pharmaceutical agent
#546Method of treating a pathological syndrome and a pharmaceutical agent
#547Biomarkers for pneumonia and acute decompensated heart failure
#548Composition for elastin production
#549Anti-erythropoietin antibodies
#550Diagnosis and risk stratification by determining the marker CT-proADM
#551Human antibodies to human angiopoietin-like protein 4
#552Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such
#553Anti-big-endothelin-1 (big-ET-1) antibodies and uses thereof
#554Antibodies that bind myostatin, compositions and methods
#555Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment for use in therapy
#556Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
#557Anti-hepcidin antibodies and uses thereof
#558Methods of determination of activation or inactivation of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems
#559Method for increasing natriuresis or diuresis by isoforms of brain natriuretic peptide
#560Method for the selective detection and measurement of procalcitonin 1-116 and amino-terminal peptides of procalcitonin comprising amino acids 1 and 2 of procalcitonin 1-116
#561Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
#562Immunoassay for chromogranin A, antibodies and kit
#563Immunoassay for quantification of an unstable antigen selected from BNP and proBNP
#564Methods of treating diabetes and compositions capable of same
#565Antibody against human TSH and canine TSH
#566ANTIBODIES AGAINST N-PROCALCITONIN
#567GROWTH HORMONE RECEPTOR DEFICIENCY CAUSES A MAJOR REDUCTION IN PRO-AGING SIGNALING, CANCER AND DIABETES IN HUMANS
#568METHODS OF PRODUCING HYBRIDOMAS AND MONOCLONAL ANTIBODIES AND ANTIBODIES PRODUCED THEREBY
#569PREDICTION AND PREVENTION OF PREECLAMPSIA
#570Methods for predicting pregnancy outcome in a subject by hCG assay
#571HUMAN INSULIN ASSAY AND ASSAY REAGENT
#572TSH immunoassays and processes for performing TSH immunoassays in the presence of endogenous contaminants in restricted wash formats
#573TSH antibodies for point-of-care immunoassay formats
#574Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
#575Anti-CGRP compositions and use thereof
#576Medicament and a method for regulation of the vascular tone
#577Dual Variable Domain Immunoglobulins and Uses Thereof
#578Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
#579Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
#580Immunoassay tracer reagents and methods for measuring the amount of native human bioactive hepcidin
#581METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST
#582Deoxycorticosterone induced elastin production
#583TRI-VARIABLE DOMAIN BINDING PROTEINS AND USES THEREOF
#584Therapeutic compositions and methods for the prevention of autoimmune diseases
#585Monoclonal antibodies to progastrin
#586INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#587Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
#588Anti-LPS enriched immunoglobulin preparations for the treatment and/or prophylaxis of a pathologic disorder
#589METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#590HUMAN NT-PRO B-TYPE NATRIURETIC PEPTIDE ASSAY HAVING REDUCED CROSS-REACTIVITY WITH OTHER PEPTIDE FORMS
#591IMMUNOASSAY FOR THE DETECTION OF PROCALCITONIN
#592ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER
#593COMPOSITIONS AND METHODS FOR DEMONSTRATING SECRETORY IMMUNE SYSTEM REGULATION OF STEROID HORMONE RESPONSIVE CANCER CELL GROWTH
#594Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP
#595Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
#596Method for reducing immunogenicity of therapeutic protein compositions
#597DYSFUNCTION OF THE MITOCHONDRIAL RESPIRATORY CHAIN, METHODS FOR DIAGNOSIS, TREATMENT AND FOLLOW-UP
#598Monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
#599Albumin fusion proteins
#600Signal biomarkers